{"id":6710,"date":"2019-01-21T09:32:00","date_gmt":"2019-01-21T09:32:00","guid":{"rendered":"https:\/\/genekor.dermtherapy.gr\/2023\/12\/12\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/"},"modified":"2023-12-19T09:54:49","modified_gmt":"2023-12-19T09:54:49","slug":"o-noua-era-in-ceea-ce-priveste-cancerul-de-san","status":"publish","type":"post","link":"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/","title":{"rendered":"O nou\u0103 er\u0103 \u00een ceea ce prive\u0219te cancerul de s\u00e2n!"},"content":{"rendered":"\n<p>Rezultatele recente ale studiului Trial Assigning IndividuaLized Options for Treatment &#8211; RX (TAILORx), cel mai mare studiu clinic pentru cancerul de s\u00e2n realizat vreodat\u0103, la care au participat peste 10.000 de pacien\u021bi, au ar\u0103tat \u00een sf\u00e2r\u0219it c\u0103 peste 70% dintre femeile cu cancer de s\u00e2n \u00een stadiu incipient nu beneficiaz\u0103 de chimioterapie.<\/p>\n\n<p>Cancerul de s\u00e2n este cunoscut ca fiind cel mai frecvent tip de cancer la femei \u00een zilele noastre, cu peste 1.600.000 de cazuri pe an la nivel mondial.<\/p>\n\n<p>Chiar dac\u0103 rata cancerului de s\u00e2n \u00een r\u00e2ndul femeilor este mai mare ca niciodat\u0103, vestea bun\u0103 este c\u0103 acesta are un prognostic bun dac\u0103 este diagnosticat \u00eentr-un stadiu incipient. Cu toate acestea, ratele de mortalitate au sc\u0103zut semnificativ, iar principalul motiv pentru acest lucru este noua er\u0103 a oncologiei moleculare, care ne introduce \u00een profilarea molecular\u0103 a fiec\u0103rui pacient cu cancer pentru a personaliza tratamentul \u00een func\u021bie de caracteristicile moleculare unice ale acestuia.<\/p>\n\n<p>Oncotype DX\u00ae Breast Recurrence Score este singurul test aprobat de toate ghidurile majore de practic\u0103 clinic\u0103 acceptate la nivel interna\u021bional \u0219i este singurul test prognostic \u0219i predictiv pentru pacientele cu cancer de s\u00e2n \u00een stadiu incipient cu receptori de estrogen (ER) pozitivi \u0219i HER-2 negativ. Oncotype DX\u00ae Breast Recurrence Score identific\u0103 probabilitatea de a beneficia de chimioterapie pentru fiecare pacient\u0103 \u0219i cuantific\u0103, de asemenea, riscul de recidiv\u0103 la distan\u021b\u0103 pentru fiecare pacient\u0103 cu cancer de s\u00e2n.<\/p>\n\n<p>Acest lucru este extrem de important, deoarece medicii sunt acum capabili s\u0103 clasifice pacien\u021bii \u00een subgrupuri \u00een func\u021bie de caracteristicile lor clinice \u0219i de rezultatele ob\u021binute la Recurrence Score\u00ae \u0219i s\u0103 elaboreze cel mai potrivit plan de tratament pentru fiecare dintre ei. Acum putem vorbi cu siguran\u021b\u0103 de o nou\u0103 er\u0103 a tratamentului personalizat al cancerului, l\u0103s\u00e2nd \u00een urm\u0103 toate planurile de tratament &#8222;unul pentru to\u021bi&#8221;, care s-au dovedit a fi o op\u021biune inexact\u0103 pentru multe cazuri.<\/p>\n\n<p>Scorul de recuren\u021b\u0103 mamar\u0103 Oncotype DX\u00ae Breast Recurrence Score este realizat \u00een Redwood, SUA. De c\u0103tre Genomic Health, Inc. \u0219i este distribuit \u00een exclusivitate pe pia\u021ba noastr\u0103 local\u0103 de c\u0103tre Genekor Medical S.A.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rezultatele recente ale studiului Trial Assigning IndividuaLized Options for Treatment &#8211; RX (TAILORx), cel mai mare studiu clinic pentru cancerul de s\u00e2n realizat vreodat\u0103, la care au participat peste 10.000 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":6711,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33],"tags":[],"class_list":["post-6710","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-ro"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.0 (Yoast SEO v24.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>O nou\u0103 er\u0103 \u00een ceea ce prive\u0219te cancerul de s\u00e2n! - Genekor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"O nou\u0103 er\u0103 \u00een ceea ce prive\u0219te cancerul de s\u00e2n!\" \/>\n<meta property=\"og:description\" content=\"Rezultatele recente ale studiului Trial Assigning IndividuaLized Options for Treatment &#8211; RX (TAILORx), cel mai mare studiu clinic pentru cancerul de s\u00e2n realizat vreodat\u0103, la care au participat peste 10.000 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/\" \/>\n<meta property=\"og:site_name\" content=\"Genekor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/genekorbiotechnology\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-21T09:32:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-19T09:54:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/1246-breastcancer_survivor_experience-1296x728-header.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1296\" \/>\n\t<meta property=\"og:image:height\" content=\"728\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Faykay22\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"Faykay22\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/\"},\"author\":{\"name\":\"Faykay22\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/86dcc4a1fea0667dffb2244541e4149e\"},\"headline\":\"O nou\u0103 er\u0103 \u00een ceea ce prive\u0219te cancerul de s\u00e2n!\",\"datePublished\":\"2019-01-21T09:32:00+00:00\",\"dateModified\":\"2023-12-19T09:54:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/\"},\"wordCount\":374,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/genekor.com\/ro\/#organization\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/1246-breastcancer_survivor_experience-1296x728-header.jpeg\",\"articleSection\":[\"Uncategorized @ro\"],\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/\",\"url\":\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/\",\"name\":\"O nou\u0103 er\u0103 \u00een ceea ce prive\u0219te cancerul de s\u00e2n! - Genekor\",\"isPartOf\":{\"@id\":\"https:\/\/genekor.com\/ro\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/1246-breastcancer_survivor_experience-1296x728-header.jpeg\",\"datePublished\":\"2019-01-21T09:32:00+00:00\",\"dateModified\":\"2023-12-19T09:54:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#primaryimage\",\"url\":\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/1246-breastcancer_survivor_experience-1296x728-header.jpeg\",\"contentUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/1246-breastcancer_survivor_experience-1296x728-header.jpeg\",\"width\":1296,\"height\":728},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/genekor.com\/ro\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"O nou\u0103 er\u0103 \u00een ceea ce prive\u0219te cancerul de s\u00e2n!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genekor.com\/ro\/#website\",\"url\":\"https:\/\/genekor.com\/ro\/\",\"name\":\"Genekor\",\"description\":\"Medicina personalizat\u0103\",\"publisher\":{\"@id\":\"https:\/\/genekor.com\/ro\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genekor.com\/ro\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/genekor.com\/ro\/#organization\",\"name\":\"Genekor\",\"url\":\"https:\/\/genekor.com\/ro\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg\",\"contentUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg\",\"width\":1,\"height\":1,\"caption\":\"Genekor\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/genekorbiotechnology\/\",\"https:\/\/gr.linkedin.com\/company\/genekor-sa\",\"https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/86dcc4a1fea0667dffb2244541e4149e\",\"name\":\"Faykay22\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9a60087a414006a2c76f910bb7465ef4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9a60087a414006a2c76f910bb7465ef4?s=96&d=mm&r=g\",\"caption\":\"Faykay22\"},\"sameAs\":[\"https:\/\/genekor.websters.gr\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"O nou\u0103 er\u0103 \u00een ceea ce prive\u0219te cancerul de s\u00e2n! - Genekor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/","og_locale":"ro_RO","og_type":"article","og_title":"O nou\u0103 er\u0103 \u00een ceea ce prive\u0219te cancerul de s\u00e2n!","og_description":"Rezultatele recente ale studiului Trial Assigning IndividuaLized Options for Treatment &#8211; RX (TAILORx), cel mai mare studiu clinic pentru cancerul de s\u00e2n realizat vreodat\u0103, la care au participat peste 10.000 [&hellip;]","og_url":"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/","og_site_name":"Genekor","article_publisher":"https:\/\/www.facebook.com\/genekorbiotechnology\/","article_published_time":"2019-01-21T09:32:00+00:00","article_modified_time":"2023-12-19T09:54:49+00:00","og_image":[{"width":1296,"height":728,"url":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/1246-breastcancer_survivor_experience-1296x728-header.jpeg","type":"image\/jpeg"}],"author":"Faykay22","twitter_card":"summary_large_image","twitter_misc":{"Scris de":"Faykay22","Timp estimat pentru citire":"2 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#article","isPartOf":{"@id":"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/"},"author":{"name":"Faykay22","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/86dcc4a1fea0667dffb2244541e4149e"},"headline":"O nou\u0103 er\u0103 \u00een ceea ce prive\u0219te cancerul de s\u00e2n!","datePublished":"2019-01-21T09:32:00+00:00","dateModified":"2023-12-19T09:54:49+00:00","mainEntityOfPage":{"@id":"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/"},"wordCount":374,"commentCount":0,"publisher":{"@id":"https:\/\/genekor.com\/ro\/#organization"},"image":{"@id":"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/1246-breastcancer_survivor_experience-1296x728-header.jpeg","articleSection":["Uncategorized @ro"],"inLanguage":"ro-RO","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/","url":"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/","name":"O nou\u0103 er\u0103 \u00een ceea ce prive\u0219te cancerul de s\u00e2n! - Genekor","isPartOf":{"@id":"https:\/\/genekor.com\/ro\/#website"},"primaryImageOfPage":{"@id":"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#primaryimage"},"image":{"@id":"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/1246-breastcancer_survivor_experience-1296x728-header.jpeg","datePublished":"2019-01-21T09:32:00+00:00","dateModified":"2023-12-19T09:54:49+00:00","breadcrumb":{"@id":"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#primaryimage","url":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/1246-breastcancer_survivor_experience-1296x728-header.jpeg","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/1246-breastcancer_survivor_experience-1296x728-header.jpeg","width":1296,"height":728},{"@type":"BreadcrumbList","@id":"https:\/\/genekor.com\/ro\/2019\/01\/21\/o-noua-era-in-ceea-ce-priveste-cancerul-de-san\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genekor.com\/ro\/"},{"@type":"ListItem","position":2,"name":"O nou\u0103 er\u0103 \u00een ceea ce prive\u0219te cancerul de s\u00e2n!"}]},{"@type":"WebSite","@id":"https:\/\/genekor.com\/ro\/#website","url":"https:\/\/genekor.com\/ro\/","name":"Genekor","description":"Medicina personalizat\u0103","publisher":{"@id":"https:\/\/genekor.com\/ro\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genekor.com\/ro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Organization","@id":"https:\/\/genekor.com\/ro\/#organization","name":"Genekor","url":"https:\/\/genekor.com\/ro\/","logo":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/","url":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","width":1,"height":1,"caption":"Genekor"},"image":{"@id":"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/genekorbiotechnology\/","https:\/\/gr.linkedin.com\/company\/genekor-sa","https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA"]},{"@type":"Person","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/86dcc4a1fea0667dffb2244541e4149e","name":"Faykay22","image":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9a60087a414006a2c76f910bb7465ef4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9a60087a414006a2c76f910bb7465ef4?s=96&d=mm&r=g","caption":"Faykay22"},"sameAs":["https:\/\/genekor.websters.gr"]}]}},"_links":{"self":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/6710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/comments?post=6710"}],"version-history":[{"count":1,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/6710\/revisions"}],"predecessor-version":[{"id":6712,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/6710\/revisions\/6712"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/media\/6711"}],"wp:attachment":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/media?parent=6710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/categories?post=6710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/tags?post=6710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}